Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $6,500.00 |
|---|---|
| Enterprise Value | $7.67 Million |
| Earnings per Share | $-0.63 |
| Beta | 0.41 |
| Outstanding Shares | 64,998,838 |
| P/E Ratio | -2.78 |
|---|---|
| PEG | 28.42 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.36 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.25 |
| Debt to Equity | 0.5 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mecha...